1 |
Cyclosporine-associated thrombotic microangiopathy in renal allografts.  |
미소장 |
2 |
CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION  |
미소장 |
3 |
Thrombotic microangiopathy after renal transplantation in the United States.  |
미소장 |
4 |
Increased Risk of Thrombotic Microangiopathy in Patients Receiving a Cyclosporin–Sirolimus Combination  |
미소장 |
5 |
De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination1  |
미소장 |
6 |
Mycophenolate Mofetil and Prednisolone as Maintenance Therapy in Hemolytic Uremic Syndrome after Kidney Transplantation  |
미소장 |
7 |
Taylor CM, Neild G. Acute renal failure associated with microangiopathy (haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura). In: Davison A, Cameron JS, Grunfeld JP, Ponticelli C, Ritz E, Winearls C, et al., eds. Oxford textbook of clinical nephrology. 3rd ed. Oxford: Oxford University Press: 2005:1545-64. |
미소장 |
8 |
Mor E, Lustig S, Tovar A, Bar-Nathan N, Shharabani E, Shapira Z, et al. Thrombotic microangiopathy early after kidney transplantation: hemolytic uremic syndrome or vascular rejection? Transplant Proc 2000;32:686-7. |
미소장 |
9 |
Outcome of Plasma Exchange Therapy in Thrombotic Microangiopathy After Renal Transplantation  |
미소장 |
10 |
Costimulation Blockade with Belatacept in Renal Transplantation  |
미소장 |
11 |
Successful treatment of hemolytic uremic syndrome after liver-kidney transplantation  |
미소장 |
12 |
Calcineurin Inhibitor‐Free Immunosuppression in Renal Allograft Recipients with Thrombotic Microangiopathy/Hemolytic Uremic Syndrome  |
미소장 |
13 |
Thrombotic Microangiopathy after Lung Transplantation  |
미소장 |
14 |
Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?  |
미소장 |
15 |
Successful treatment of tacrolimus-associated thrombotic microangiopathy with sirolimus conversion and plasma exchange.  |
미소장 |
16 |
Calcineurin inhibitor nephrotoxicity.  |
미소장 |
17 |
Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.  |
미소장 |
18 |
Ponticelli C. De novo thrombotic microangiopathy. An underrated complication of renal transplantation. Clin Nephrol 2007;67:335-40. |
미소장 |
19 |
Post-transplant hemolytic-uremic syndrome.  |
미소장 |
20 |
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.  |
미소장 |
21 |
IMPACT OF IMMUNOSUPPRESSIVE TREATMENTS ON ENDOTHELIAL BIOMARKERS AFTER KIDNEY TRANSPLANTATION  |
미소장 |
22 |
VEGF inhibition and renal thrombotic microangiopathy.  |
미소장 |
23 |
Differential Impact of Belatacept and Cyclosporine A On Central Aortic Blood Pressure and Arterial Stiffness After Renal Transplantation.  |
미소장 |
24 |
The role of novel T cell costimulatory pathways in autoimmunity and transplantation.  |
미소장 |
25 |
Challenges and opportunities in targeting the costimulation pathway in solid organ transplantation  |
미소장 |
26 |
A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)  |
미소장 |
27 |
A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation.  |
미소장 |
28 |
Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy.  |
미소장 |
29 |
Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients  |
미소장 |